SORRENTO THERAPEUTICS
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SRNE and buy or sell other stocks, ETFs, and their options commission-free!About SRNE
Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments.
CEOHenry H. Ji, PhD
CEOHenry H. Ji, PhD
Employees—
Employees—
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1989
Founded1989
Employees—
Employees—
SRNE Key Statistics
Market cap4.96M
Market cap4.96M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume689.32K
Average volume689.32K
High today$0.009
High today$0.009
Low today$0.003
Low today$0.003
Open price$0.0075
Open price$0.0075
Volume213.45K
Volume213.45K
52 Week high$0.0985
52 Week high$0.0985
52 Week low$0.0001
52 Week low$0.0001
Stock Snapshot
SORRENTO THERAPEUTICS(SRNE) stock is priced at $0.01, giving the company a market capitalization of 4.96M.
During the trading session on 2025-11-16, SORRENTO THERAPEUTICS(SRNE) shares reached a daily high of $0.01 and a low of $0.00. At a current price of $0.01, the stock is +200.0% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 213.45K, compared to an average daily volume of 689.32K.
The stock's 52-week range extends from a low of $0.00 to a high of $0.10.
The stock's 52-week range extends from a low of $0.00 to a high of $0.10.
People also own
Based on the portfolios of people who own SRNE. This list is generated using Robinhood data, and it’s not a recommendation.